by LISTSERV.REDIRIS.ES (LISTSERV-TCP/IP release 16.0) with spool id
11300753 for [log in para visualizar]; Mon, 6 Apr 2020 20:09:45
+0200
from mx01.puc.rediris.es (outbound5mad.lav.puc.rediris.es
[130.206.19.148]) by listserv.rediris.es (Postfix) with ESMTP id
7EDE9233B8 for <[log in para visualizar]>; Mon, 6 Apr 2020
20:09:45 +0200 (CEST)
from lsv.rediris.es (lsv.rediris.es [130.206.1.61]) by
mx01.puc.rediris.es with SMTP id 036I9iET030686-036I9iEU030686; Mon,
6 Apr 2020 20:09:44 +0200
Financing and Scaling Innovation for the COVID Fight: A Closer Look at Demand-Side Incentives for a Vaccine
A COVID-19 vaccine is needed now, but timelines (12-18 months) create large market risk. By the time a vaccine is ready, the crisis may have passed. A CGD Note explores three options: business as usual – which may lead to promotion of an inferior vaccine or fierce country competition for supply – and two models (cost- or value-based), with countries pre-committing to purchases meeting specified efficacy. The authors prefer a value-based model.
Available at: https://www.ohe.org/news/financing-and-scaling-innovation-covid-fight-closer-look-demand-side-incentives-vaccine